Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,812 | 499 | 1,762 | 1,877 | 1,046 |
| Other current assets | 56 | 32 | 64 | 65 | 0 |
| TOTAL | $1,917 | $554 | $1,853 | $1,946 | $1,047 |
| Non-Current Assets | |||||
| PPE Net | 269 | 233 | 174 | 192 | N/A |
| Intangibles | 255 | 262 | 273 | 258 | N/A |
| Other Non-Current Assets | 224 | 0 | 0 | 0 | 0 |
| TOTAL | $747 | $495 | $447 | $449 | $0 |
| Total Assets | $2,665 | $1,050 | $2,300 | $2,396 | $1,047 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,579 | N/A | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 113 | 61 | 91 | 7 | 144 |
| TOTAL | $1,779 | $182 | $168 | $264 | $144 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,144 | 1,173 | 0 | N/A |
| Other Non-Current Liabilities | 15 | 3 | 0 | 0 | 0 |
| TOTAL | $10 | $1,217 | $1,173 | $0 | $0 |
| Total Liabilities | $1,789 | $1,399 | $1,340 | $264 | $144 |
| Shareholders' Equity | |||||
| Common Shares | 4,336 | 3,612 | 3,602 | 3,601 | 669 |
| Retained earnings | -8,036 | -5,953 | -4,482 | -3,007 | -607 |
| Other shareholders' equity | -5,401 | -5,705 | -5,501 | -5,803 | 0 |
| TOTAL | $891 | $-347 | $959 | $2,132 | $904 |
| Total Liabilities And Equity | $2,680 | $1,052 | $2,300 | $2,396 | $1,047 |